Abstract
Descriptions of mental illness exist throughout recorded history. However, until the mid-twentieth century, there was no standard nosology or diagnostic standard for mental disorders. This limited understanding of these disorders and development of better treatments. As conditions such as dementia praecox and schizophrenia were being described, collaborative efforts were made in the twentieth century to develop the first Diagnostic and Statistical Manual of Mental Disorders (DSM). This review provides an overview of the history of psychiatric diagnosis with a focus on the history of schizophrenia as a diagnosis in the DSM. DSM-5 updates to diagnostic criteria for schizophrenia and related disorders are provided. Limitations to diagnostic validity and reliability are discussed in addition to changes in diagnostic approaches to schizophrenia spectrum and other psychotic disorders in an effort to improve diagnostic validity and reliability. The DSM-5 reflects the culmination of an ongoing collaborative effort to improve the diagnosis of mental disorders, and future research in Research Domain Criteria (RDoC) will help provide convergent validity when understanding and treating mental illnesses.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Ludwig CS, Papyros Ebers: Das hermetische Buch über die Arzeneimittel der alten Ägypter in hieratischer Schrift, herausgegeben mit Inhaltsangabe und Einleitung versehen von Georg Ebers, mit Hieroglyphisch-Lateinischem Glossar von Ludwig Stern, mit Unterstützung des Königlich Sächsischen Cultusministerium (in German), G. Ebers, Editor 1875.
Tandon R. Schizophrenia and other Psychotic Disorders in DSM-5. Clin Schizophr Relat Psychoses. 2013;7:16–9.
Clegg JW. Teaching about mental health and illness through the history of the DSM. Hist Psychol. 2012;15:364–70.
•• Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Association; 2013. This is the most recent version of the DSM.
Kim Y. Historical perspective of PTSD and future revision in DSM-5. Seishin Shinkeigaku Zasshi. 2012;114:1031–6.
Matsunaga H. Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5. Seishin Shinkeigaku Zasshi. 2012;114:1023–30.
Hyman SE. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci. 2007;8:725–32.
Palmer RH, Button TM, Rhee SH, et al. Genetic etiology of the common liability to drug dependence: evidence of common and specific mechanisms for DSM-IV dependence symptoms. Drug Alcohol Depend. 2012;123 Suppl 1:S24–32.
Phelps J, Ghaemi SN. The mistaken claim of bipolar 'overdiagnosis': solving the false positives problem for DSM-5/ICD-11. Acta Psychiatr Scand. 2012;126:395–401.
Spitzer RL, Forman JB, Nee J. DSM-III field trials: I. Initial interrater diagnostic reliability. Am J Psychiatry. 1979;136:815–7.
• Clarke DE, Narrow WE, Regier DA, et al. DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches. Am J Psychiatry. 2013;170:43–58. Describes analytic approaches used to test reliability of selected DSM-5 diagnoses..
Adityanjee, Aderibigbe YA, Theodoridis D, et al. Dementia praecox to schizophrenia: the first 100 years. Psychiatry Clin Neurosci. 1999;53:437–48.
Berrios GE. Eugen Bleuler's place in the history of psychiatry. Schizophr Bull. 2011;37:1095–8.
Schneider K. Clinical psychopathology. New York: Grune and Stratton; 1959.
Nordgaard J, Arnfred SM, Handest P, et al. The diagnostic status of first-rank symptoms. Schizophr Bull. 2008;34:137–54.
Adam D. Mental health: on the spectrum. Nature. 2013;496:416–8.
Kupfer DJ, Kuhl EA, Regier DA. DSM-5–the future arrived. JAMA. 2013;309:1691–2.
Tsuang MT, Stone WS, Faraone SV. Toward reformulating the diagnosis of schizophrenia. Am J Psychiatry. 2000;157:1041–50.
• Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170:59–70. Provides results of how reliabilty clincians diagnose DSM-5 disorders..
Handest P, Parnas J. Clinical characteristics of first-admitted patients with ICD-10 schizotypal disorder. Br J Psychiatry Suppl. 2005;48:s49–54.
Tandon R, Gaebel W, Barch DM, et al.: Definition and description of schizophrenia in the DSM-5. Schizophr Res 2013.
Tsuang MT, Van Os J, Tandon R, et al. Attenuated psychosis syndrome in DSM-5. Schizophr Res. 2013. doi:10.1016/j.schres.2013.05.004.
Hendrickx L, Gijs L, Enzlin P. Distress, sexual dysfunctions, and DSM: dialogue at cross purposes? J Sex Med. 2013;10:630–41.
• Narrow WE, Clarke DE, Kuramoto SJ, et al. DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry. 2013;170:71–82. Provides a description of novel cross-cutting assesment measures for DSM-5 diagnoses..
Kraemer HC, Kupfer DJ, Narrow WE, et al. Moving toward DSM-5: the field trials. Am J Psychiatry. 2010;167:1158–60.
• Kraemer HC, Kupfer DJ, Clarke DE, et al. DSM-5: how reliable is reliable enough. Am J Psychiatry. 2012;169:13–5. Discusses limits and approaches to more accurately diagnosing mental disorders..
NIMH Research Domain Criteria (RDoC). Available from: http://www.nimh.nih.gov/research-priorities/rdoc/nimh-research-domain-criteria-rdoc.shtml.
Schmeck K, Schluter-Muller S, Foelsch PA, et al. The role of identity in the DSM-5 classification of personality disorders. Child Adolesc Psychiatr Ment Health. 2013;7:27.
Stein DJ, Lund C, Nesse RM. Classification systems in psychiatry: diagnosis and global mental health in the era of DSM-5 and ICD-11. Curr Opin Psychiatr. 2013;26:493–7.
Andrews G, Goldberg DP, Krueger RF, et al. Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychol Med. 2009;39:1993–2000.
Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160:4–12.
Compliance with Ethics Guidelines
Conflict of Interest
Mahendra T. Bhati has received research support from the American Psychiatric Association for the University of Pennsylvania’s DSM-5 field trial. He has received payment for a lecture from PA Community Health Center Collaborative and research support from Medtronic, Cyberonics, NeoSync, and National Institute of Mental Health. He has provided expert testimony to Dechert, LLC, for which his institution has received financial support.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Schizophrenia and Other Psychotic Disorders
Rights and permissions
About this article
Cite this article
Bhati, M.T. Defining Psychosis: The Evolution of DSM-5 Schizophrenia Spectrum Disorders. Curr Psychiatry Rep 15, 409 (2013). https://doi.org/10.1007/s11920-013-0409-9
Published:
DOI: https://doi.org/10.1007/s11920-013-0409-9